RxDoctor Payments Data

Richard Cline, DO

Family Medicine · Fayetteville, TNNPI 1043357916

Payments from drug & device makers

$9,581in general payments, 2019–2025

Across 626 payments — averaging $15.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • Amgen$980
  • AbbVie$916
  • Lilly USA, LLC$532
  • Merck$498
  • Pfizer$443
  • plus $5K from 37 others

What the payments were for

  • Food & beverage$9,566100%
  • Education$150%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,581 in reported general payments places this provider in the 90th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$63,239
Medicare patients
99
Services billed
1,284

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban73$56,773
JardianceEmpagliflozin47$50,932
RybelsusSemaglutide36$39,023
JanuviaSitagliptin Phosphate43$32,730
OzempicSemaglutide35$31,148
VraylarCariprazine Hcl18$27,357
XareltoRivaroxaban19$23,763
Tresiba Flextouch U-200Insulin Degludec23$20,908
Janumet XrSitagliptin Phos/Metformin Hcl19$16,363
LinzessLinaclotide21$16,230
JanumetSitagliptin Phos/Metformin Hcl11$14,265
GemtesaVibegron18$13,585
KerendiaFinerenone19$12,425
Tresiba Flextouch U-100Insulin Degludec14$12,024
MultaqDronedarone Hcl11$8,525

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$1,544$70,17171 claims
MerckJanuvia, Janumet Xr, Janumet$498$63,35873 claims
PfizerEliquis, Abrysvo$443$60,28684 claims
Boehringer IngelheimJardiance$339$50,93247 claims
AbbVieVraylar, Linzess$916$43,58739 claims
Johnson & JohnsonXarelto$216$23,76319 claims
Sumitomo Pharma America, Inc.Gemtesa$22$13,58518 claims
BayerKerendia$263$12,42519 claims
Sanofi-aventis U.S. LLCMultaq$183$8,52511 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$224$8,01511 claims
GSKTrelegy Ellipta$62$7,71412 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$67$2,224309 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Fayetteville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →